00:00 - Introduction to Lily and GLife’s vision for data-driven dermatology

01:20 - Lily’s scientific background

02:43 - Breakthroughs from single-cell atlases

03:50 - The motivation behind founding GLife

04:50 - The importance of treating skin as a foundational organ

05:48 - Discovery of key molecular drivers of aging

06:22 - Challenges of fundraising

07:45 - The novel approach to rejuvenating hair loss through targeted messenger RNA treatments

08:53 - How treatments will be delivered via microneedles and micro patches

09:32 - The potential to alter hair color and explore cosmetic applications

10:06 - Balancing platform discovery engines with the development of first-in-class therapeutics

10:43 - The comprehensiveness of the skin atlas and addressing genetic diversity

11:39 - Technical challenges of capturing skin’s cellular heterogeneity and stem cell populations

12:50 - The importance of isoforms and deep sequencing in understanding gene functions

13:16 - Short-lived messenger RNA as a safe, reversible treatment modality

14:55 - Safety considerations and toxicity management

16:01 - Biodistribution studies and local micro-needle delivery safety

17:00 - Next steps towards clinical trials and regenerative therapies for hair loss

18:08 - The role of big data and omics in understanding skin disorders and aging

19:04 - The significance of isoforms in skin biology and gene function

20:13 - Endogenous vs. modified messenger design for safety and efficacy

21:32 - Potential for multi-gene delivery to enhance hair regrowth and color restoration

22:22 - Conception of patches that work with existing hair without shaving

23:38 - Targeting broad hair loss types and the concept of root causes

24:47 - Modeling hair loss with animal models and regulatory considerations

25:48 - Regulatory perspectives on non-animal models and validation strategies

26:34 - The interplay between genetic and environmental causes of skin aging

27:54 - The biological hub role of specific transcription factors in stress and aging

29:10 - The future of skin biomarkers for diagnosis and personalized health monitoring

30:18 - Leveraging AI’s data integration and precision medicine in dermatology

32:32 - The impact of protein isoforms and post-translational modifications in skin treatment

34:47 - Interest in peptides, small molecules, and biohacking trends for skin health

36:03 - Collaboration between wet labs, computational teams, and clinical partners

36:36 - The significance of internal naming conventions in research and development

37:28 - The high-throughput screening process for key transcription factors

38:13 - Strategies for overexpressing target genes in therapeutic design

39:00 - AI’s role in accelerating discovery and development pipelines in biotech

40:39 - Addressing data quality, heterogeneity, and integration challenges in big datasets

44:12 - Envisioning personalized skincare driven by genomics and AI

44:56 - The inspiring concept that ancient technologies now seem like magic

45:24 - Challenges in bringing novel dermatological treatments through trials and regulation

47:42 - The evolving role of AI in drug quality control and documentation

48:11 - Unique advantages of Lily’s targeted mRNA approach over other modalities

49:22 - Using skin as a model system for broader human biology insights

50:28 - Perspectives on epigenetic reprogramming and cellular re-differentiation

51:22 - Fundraising experiences and strategic positioning for biotech development

52:21 - The influence of science fiction, especially “Three Body Problem” and “Interstellar,” on Lily’s vision

54:24 - Advice to young scientists: read widely, think deeply, and dream big